Skip to main content
Clinical Trials/NCT03195309
NCT03195309UnknownPhase 1

A Comparison of Different Concentration Ropivacaine Combination With Fentanyl for Patient-controlled Epidural Analgesia After Cesarean Delivery

Kaohsiung Medical University Chung-Ho Memorial Hospital1 site in 1 country120 target enrollmentStarted: January 20, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 1
Enrollment
120
Locations
1
Primary Endpoint
Change From Baseline in Pain Scores on the numeric rating scale

Study Overview

Brief Summary

To compare the postoperative analgesic effect and the intensity of motor block in different concentration ropivacaine plus fentanyl when used epidurally with a patient-controlled analgesia device after Cesarean delivery.

Detailed Description

  1. Written informed consent must be obtained before any study specific procedures are undertaken.
  2. All patients were received epidural anesthesia with 2% Lidocaine and patient-controlled epidural analgesia (PCEA) for post- operative pain control. PCEA randomly allocated into three groups. Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl, Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl, and Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl. Dermographic data, dosage of PCEA during first 48 hours post-operation,NRS scores, patient satisfaction and the intensity of motor block will be recorded and analyzed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Masking Description

Participant do not know which formula they are receive. Nor do the daily care providers.

Eligibility Criteria

Ages
20 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female undergoing elective Cesarean delivery and receive patient-controlled epidural analgesia

Exclusion Criteria

  • With the comorbidity of chronic heart, lung, liver and renal disease, chronic alcoholism, allergy to ropivacaine, poor epidural function and combine other anesthesia method

Arms & Interventions

Group A

Active Comparator

Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl

Intervention: Ropivacaine (Drug)

Group A

Active Comparator

Group A patients received 0.08% ropivacaine plus 4 mcg /mL fentanyl

Intervention: Fentanyl (Drug)

Group B

Active Comparator

Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl

Intervention: Ropivacaine (Drug)

Group B

Active Comparator

Group B patients received 0.08% ropivacaine plus 2mcg /mL fentanyl

Intervention: Fentanyl (Drug)

Group C

Active Comparator

Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl

Intervention: Ropivacaine (Drug)

Group C

Active Comparator

Group C patients received 0.16 % ropivacaine plus 2 mcg /mL fentanyl

Intervention: Fentanyl (Drug)

Outcomes

Primary Outcomes

Change From Baseline in Pain Scores on the numeric rating scale

Time Frame: The investigators measured numeric score changing at 5 different timing. The first is when arrival post-operative care unit, the second is when arrival post-operative care unit for 2 hours. And then 6,24,48 hours after operation.

The investigators use numeric rating scale(0\~10) for pain severity measurement, 0 for no pain, 10 is the most severe pain

Secondary Outcomes

  • Change From Baseline in Patient satisfaction scale(The investigators measured numeric score changing at 5 different timing. The first is when arrival post-operative care unit, the second is when arrival post-operative care unit for 2 hours. And then 6,24,48 hours after operation.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

A Comparison of Different Concentration... | Clinical Trial